Bai Xue, Zhu Qiang, Combs Matthew, Wabitsch Martin, Mack Christopher P, Taylor Joan M
University of North Carolina at Chapel Hill.
Ulm University Medical Center.
Res Sq. 2023 Dec 19:rs.3.rs-3740465. doi: 10.21203/rs.3.rs-3740465/v1.
Adipose tissue, which is crucial for the regulation of energy within the body, contains both white and brown adipocytes. White adipose tissue (WAT) primarily stores energy, while brown adipose tissue (BAT) plays a critical role in energy dissipation as heat, offering potential for therapies aimed at enhancing metabolic health. Regulation of the RhoA/ROCK pathway is crucial for appropriate specification, differentiation and maturation of both white and brown adipocytes. However, our knowledge of how this pathway is controlled within specific adipose depots remains unclear, and to date a RhoA regulator that selectively controls adipocyte browning has not been identified. Our study shows that expression of GRAF1, a RhoGAP highly expressed in metabolically active tissues, closely correlates with brown adipocyte differentiation in culture and in vivo. Mice with either global or adipocyte-specific GRAF1 deficiency exhibit impaired BAT maturation, reduced capacity for WAT browning, and compromised cold-induced thermogenesis. Moreover, defects in differentiation of mouse or human GRAF1-deficient brown preadipocytes can be rescued by treatment with a Rho kinase inhibitor. Collectively, these studies indicate that GRAF1 can selectively induce brown and beige adipocyte differentiation and suggest that manipulating GRAF1 activity may hold promise for the future treatment of diseases related to metabolic dysfunction.
脂肪组织对体内能量调节至关重要,包含白色和棕色脂肪细胞。白色脂肪组织(WAT)主要储存能量,而棕色脂肪组织(BAT)在以热量形式消耗能量方面起关键作用,为旨在改善代谢健康的治疗提供了潜力。RhoA/ROCK信号通路的调节对于白色和棕色脂肪细胞的适当特化、分化和成熟至关重要。然而,我们对该信号通路在特定脂肪库中如何被控制的了解仍不清楚,并且迄今为止尚未鉴定出选择性控制脂肪细胞褐变的RhoA调节剂。我们的研究表明,GRAF1(一种在代谢活跃组织中高度表达的RhoGAP)的表达与培养物中和体内的棕色脂肪细胞分化密切相关。全身性或脂肪细胞特异性GRAF1缺陷的小鼠表现出BAT成熟受损、WAT褐变能力降低以及冷诱导产热受损。此外,用Rho激酶抑制剂处理可以挽救小鼠或人类GRAF1缺陷的棕色前脂肪细胞的分化缺陷。总体而言,这些研究表明GRAF1可以选择性诱导棕色和米色脂肪细胞分化,并表明操纵GRAF1活性可能为未来治疗与代谢功能障碍相关的疾病带来希望。